Enhanced delivery of daidzein into fibroblasts and neuronal cells with cationic derivatives of gamma-cyclodextrin for the control of cellular glycosaminoglycans

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 91, Issue , 2015, Pages 111-119

  Kamiński, Kamil ^a   Kujdowicz, Monika ^a   Kajta, Małgorzata ^b   Nowakowska, Maria ^a   Szczubiałka, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Daidzein; Fibroblasts; Glycosaminoglycans; Hippocampal neuronal cells; Mucopolysaccharidosis; cyclodextrin

Indexed keywords

BIOPOLYMER; DAIDZEIN; ETHYLENEDIAMINE; GAMMA CYCLODEXTRIN; GLYCIDYLTRIMETHYLAMMONIUM CHLORIDE; GLYCOSAMINOGLYCAN; HEPARIN; MUCIN; UNCLASSIFIED DRUG; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; EPOXIDE; ETHYLENEDIAMINE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; GLYCIDYL TRIMETHYLAMMONIUM; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CIRCULAR DICHROISM; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOUSE; NERVE CELL; NONHUMAN; ABSORPTION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HIPPOCAMPUS; LYSOSOMAL STORAGE DISEASES; METABOLISM; MUCOPOLYSACCHARIDOSES; SOLUBILITY;

ABSORPTION, PHYSIOLOGICAL; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; EPOXY COMPOUNDS; ETHYLENEDIAMINES; FIBROBLASTS; GAMMA-CYCLODEXTRINS; GLYCOSAMINOGLYCANS; HIPPOCAMPUS; HUMANS; INDICATORS AND REAGENTS; ISOFLAVONES; LYSOSOMAL STORAGE DISEASES; MICE; MUCOPOLYSACCHARIDOSES; NEURONS; PHYTOESTROGENS; QUATERNARY AMMONIUM COMPOUNDS; SOLUBILITY;

EID: 84923364843     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.02.002     Document Type: Article

References (50)

1. A. Arfi, M. Richard, C. Gandolphe, and D. Scherman Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones J. Inherit. Metab. Dis. 33 2010 61 67
2. U.R. Bhaskara-Amrit, P.B. Agrawal, and M.M.C.G. Warmoeskerken Applications of β-cyclodextrins in textiles Autex Res. J. 11 2011 94 101
3. S.D. Bhise Effect of hydroxypropyl β-cyclodextrin inclusion complexation on solubility of fenofibrate Int. J. Res. Pharm. Biomed. Sci. 2 2011 596 604
4. D. Bongiorno, L. Ceraulo, M. Ferrugia, F. Filizzola, A. Ruggirello, and V.T. Liveri Inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin in solid phase ARKIVOC 14 2005 118 130
5. S. Chaleawlert-Umpon, O. Nuchuchua, S. Saesoo, P. Gonil, U.R. Ruktanonchai, W. Sajomsang, and N. Pimpha Effect of citrate spacer on mucoadhesive properties of a novel water-soluble cationic β-cyclodextrin-conjugated chitosan Carbohyd. Polym. 84 2011 186 194
6. Á.E. Daruházi, T. Kiss, M. Vecsernyés, L. Szente, E. Szoke, and E. Lemberkovics Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line J. Pharm. Biomed. Anal. 84 2013 112 116
7. X.B. Dou, Y. Hu, N.N. Zhao, and F.J. Xu Different types of degradable vectors from low-molecular-weight polycation-functionalized poly(aspartic acid) for efficient gene delivery Biomaterials 35 2014 3015 3026
8. K. Dwiecki, G. Neunert, P. Polewski, and K. Polewski Antioxidant activity of daidzein, a natural antioxidant, and its spectroscopic properties in organic solvents and phosphatidylcholine liposomes J. Photochem. Photobiol. B 96 2009 242 248
9. S. Etzold, and N. Juge Structural insights into bacterial recognition of intestinal mucins Curr. Opin. Struct. Biol. 28 2014 23 31
10. P. Fatehi, R. Singh, Z. Ziaee, H. Xiao, and Y. Ni Preparation and characterization of cationic poly vinyl alcohol with a low degree of substitution Eur. Polym. J. 47 2011 997 1004
11. N.S. Gandhi, and R.L. Mancera Heparin/heparan sulphate-based drugs Drug Discov. Today 15 2010 1058 1069
12. Q.X. Ji, D.Y. Zhong, R. Lü, W.Q. Zhang, J. Deng, and X.G. Chen In vitro evaluation of the biomedical properties of chitosan and quaternized chitosan for dental applications Carbohyd. Res. 344 2009 1297 1302
13. J. Jing, A. Szarpak-Jankowska, R. Guillot, I. Pignot-Paintrand, C. Picart, and R. Auzély-Velty Cyclodextrin/paclitaxel complex in biodegradable capsules for breast cancer treatment Chem. Mater. 25 2013 3867 3873
14. M. Kajta, E. Litwa, and J. Rzemieniec Isomer-nonspecific action of dichlorodiphenyltrichloroethane on aryl hydrocarbon receptor and G-protein-coupled receptor 30 intracellular signaling in apoptotic neuronal cells Mol. Cell. Endocrinol. 392 2014 90 105
15. M. Kajta, J. Rzemieniec, E. Litwa, W. Lason, M. Lenartowicz, W. Krzeptowski, and A.K. Wojtowicz The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein Neuroscience 238 2013 345 360
16. M. Kajta, A. Trotter, W. Lasoń, and C. Beyer Impact of 17b-estradiol on cytokine-mediated apoptotic effects in primary hippocampal and neocortical cell cultures Brain Res. 1116 2006 64 74
17. M. Kajta, A. Wójtowicz, M. Maćkowiak, and W. Lasoń Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling Neuroscience 158 2009 811 822
18. B. Kalaska, E. Sokolowska, and K. Kaminski Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis Eur. J. Pharmacol. 686 2012 81 89
19. K. Kamiński, B. Kałaska, P. Koczurkiewicz, M. Michalik, K. Szczubiałka, A. Mogielnicki, W. Buczko, and M. Nowakowska New arginine substituted derivative of poly(allylamine hydrochloride) for heparin reversal MedChemComm 5 2014 489 495
20. K. Kamiński, K. Szczubiałka, K. Zazakowny, R. Lach, and M. Nowakowska Chitosan derivatives as novel potential heparin reversal agents J. Med. Chem. 53 2010 4141 4147
21. A. Kloska, J. Jakóbkiewicz-Banecka, M. Narajczyk, Z. Banecka-Majkutewicz, and G. Węgrzyn Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses Metab. Brain Dis. 26 2011 1 8
22. S.V. Kurkov, and T. Loftsson Cyclodextrins Int. J. Pharm. 453 2013 167 180
23. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins: basic science and product development J. Pharm. Pharmacol. 62 2010 1607 1621
24. B. Lorkowska-Zawicka, K. Kamiński, and J. Ciejka Inactivation of heparin by cationically modified chitosan Mar. Drugs 12 2014 3953 3969
25. J. McCarthy, M.J. O'Neill, and L. Bourre Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system J. Control. Release 168 2013 28 34
26. S. Menuel, J.P. Joly, B. Courcot, J. Elysée, N.E. Ghermani, and A. Marsura Synthesis and inclusion ability of a bis-β-cyclodextrin pseudo-cryptand towards Busulfan anticancer agent Tetrahedron 63 2007 1706 1714
27. A. Mielańczyk, M. Skonieczna, K. Bernaczek, and D. Neugebauer Fluorescein nanocarriers based on cationic star copolymers with acetal linked sugar cores. Synthesis and biochemical characterization RSC Adv. 4 2014 31904 31913
28. N. Niyomtham, N. Apiratikul, K. Chanchang, P. Opanasopit, and B.E. Yingyongnarongkul Synergistic effect of cationic lipids with different polarheads, central core structures and hydrophobic tails on gene transfection efficiency Biol. Pharm. Bull. 37 2014 1534 1542
29. B. Pahari, B. Sengupta, S. Chakraborty, B. Thomas, D. McGowan, and P.K. Sengupta Contrasting binding of fisetin and daidzein in γ-cyclodextrin nanocavity J. Photochem. Photobiol., B 118 2013 33 41
30. N. Pahimanolis, A. Salminen, and P.A. Penttilä Nanofibrillated cellulose/carboxymethyl cellulose composite with improved wet strength Cellulose 20 2013 1459 1468
31. E. Piotrowska, J. Jakóbkiewicz-Banecka, S. Baran, A. Tylki-Szymańska, B. Czartoryska, A. Węgrzyn, and G. Węgrzyn Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses Eur. J. Human Genet. 14 2006 846 852
32. L.Y. Qiu, R.J. Wang, C. Zheng, Y. Jin, and Q. Jin le Beta-cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin delivery Nanomedicine (London) 5 2010 193 208
33. K.P. Sambasevam, S. Mohamad, N.M. Sarih, and N.A. Ismail Synthesis and characterization of the inclusion complex of β-cyclodextrin and azomethine Int. J. Mol. Sci. 14 2013 3671 3682
34. A. Sowmya, and S. Meenakshi A novel quaternized resin with acrylonitrile/divinylbenzene/vinylbenzyl chloride skeleton for the removal of nitrate and phosphate Chem. Eng. J. 257 2014 45 55
35. J. Stefan, B. Lorkowska-Zawicka, K. Kaminski, K. Szczubialka, M. Nowakowska, and R. Korbut The current view on biological potency of cationically modified chitosan J. Physiol. Pharmacol. 65 2014 341 347
36. V.J. Stella, and Q. He Cyclodextrins Toxicol. Pathol. 36 2008 30 42
37. Y. Sun, and A. Wan Preparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromolecules J. Appl. Polym. Sci. 105 2007 552 561
38. W. Tang, and S.c. Ng Facile synthesis of mono-6-amino-6-deoxy-α-, β-, γ-cyclodextrin hydrochlorides for molecular recognition, chiral separation and drug delivery Nat. Protoc. 3 2008 691 697
39. Z. Teng, Y. Li, Y. Niu, Y. Xu, L. Yu, and Q. Wang Cationic β-lactoglobulin nanoparticles as a bioavailability enhancer: comparison between ethylenediamine and polyethyleneimine as cationizers Food Chem. 159 2014 333 342
40. T.R. Thatiparti, A.J. Shoffstall, and H.A. Von Recum Cyclodextrin-based device coatings for affinity-based release of antibiotics Biomaterials 31 2010 2335 2347
41. D.C. Vitale, C. Piazza, B. Melilli, F. Drago, and S. Salomone Isoflavones: estrogenic activity, biological effect and bioavailability Eur. J. Drug Metab. Pharmacokinet. 38 2013 15 25
42. B.D. Wagner, N. Stojanovic, G. Leclair, and C.K. Jankowski A spectroscopic and molecular modelling study of the nature of the association complexes of Nile Red with cyclodextrins J. Incl. Phenom. Macrocycl. Chem. 45 2003 275 283
43. W.M. Wu, J. Wu, and N. Bodor Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs Pharmazie 57 2002 130 134
44. Y. Xiao, L. Yang, P. Mao, J. Yuan, Y. Deng, and L. Qu Inclusion complexes of phosphorylated daidzein derivatives with cyclodextrin: preparation and inclusion behavior study Spectrochim. Acta A 85 2012 298 302
45. K. Yannakopoulou Cationic cyclodextrins: cell penetrating agents and other diverse applications J. Drug Deliv. Sci. Technol. 22 2012 243 249
46. M. Zaman, H. Liu, H. Xiao, F. Chibante, and Y. Ni Hydrophilic modification of polyester fabric by applying nanocrystalline cellulose containing surface finish Carbohydr. Polym. 91 2013 560 567
47. M. Zhang, X. Wu, L. Zhang, Q. Zhu, and S. Gao Progress of modified polycationic vectors in gene therapy Pharm. Care Res. 13 2013 25 29
48. J. Zhou, F. Ai, B. Zhou, J. Tang, S.C. Ng, and W. Tang Hydroxyethylammonium monosubstituted cyclodextrin as chiral selector for capillary electrophoresis Anal. Chim. Acta 800 2013 95 102
49. Y. Zhou, B. Yang, and X. Ren Hyperbranched cationic amylopectin derivatives for gene delivery Biomaterials 33 2012 4731 4740
50. Q.F. Zhang, W.J. Yi, and B. Wang Linear polycations by ring-opening polymerization as non-viral gene delivery vectors Biomaterials 34 2013 5391 5401